Skip to main content
The Egyptian Journal of Internal Medicine

Table 9 Diagnostic performance of AFP and amphiregulin in differentiating HCC group from cirrhosis group

From: Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment

Marker

AUC

Sensitivity (%)

Specificity (%)

SE

P

95% CI

Cutoff

AFP

0.952

86.7

90

0.024

< 0.001*

0.906–0.999

≥ 220.0

Amphiregulin

0.817

63.3

86.7

0.053

< 0.001*

0.713–0.922

≥ 17.0

  1. AUC Area under curve, SE Standard error, CI Confidence interval
  2. *Significant
Back to article page